Accueil   Diary - News   All news HAPPYneuron announces agreement with Merck to offer first-of-its kind e-Health solution for people living with multiple sclerosis

HAPPYneuron announces agreement with Merck to offer first-of-its kind e-Health solution for people living with multiple sclerosis

HAPPYneuron- Agreement provides Merck with exclusive license to cognitive remediation training programs

 

- HAPPYneuron will be available for inclusion in Merck’s MSdialog platform for use with Rebif® (interferon beta-1a)

 

Villeurbanne, France, June 13, 2016 – Merck, a leading science and technology company, announced today that the company has entered into an agreement with HAPPYneuron, a subsidiary of SBT Group of France, in which Merck will receive an exclusive license to the company’s cognitive remediation training program for people living with multiple sclerosis (MS).

 

 

This agreement complements Merck’s broad portfolio of patient support programs in MS and underscores the company’s commitment to leveraging digital platforms and technologies to benefit patients in need. Financial terms of the deal were not disclosed.

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree